Estrogen pharmacology: indications, oral formulations, and doses of commonly prescribed estrogen compounds
Indication . | Oral formulation or type . | Daily therapy doses . |
---|---|---|
Estrogen replacement | Micronized 17β-estradiola | 1-2 mg |
Estradiol valerate | 1-2 mg | |
Conjugated equine estrogen | 0.3-1.25 mg | |
Contraception | Ethinyl estradiol | 20-50 μg |
Other | SERM | |
Osteoporosis | Raloxifene | 60 mg |
Breast cancer prophylaxis | Tamoxifen | 20 mg |
Infertility | Clomiphene | 50 mg |
Indication . | Oral formulation or type . | Daily therapy doses . |
---|---|---|
Estrogen replacement | Micronized 17β-estradiola | 1-2 mg |
Estradiol valerate | 1-2 mg | |
Conjugated equine estrogen | 0.3-1.25 mg | |
Contraception | Ethinyl estradiol | 20-50 μg |
Other | SERM | |
Osteoporosis | Raloxifene | 60 mg |
Breast cancer prophylaxis | Tamoxifen | 20 mg |
Infertility | Clomiphene | 50 mg |
Abbreviation: SERM, selective estrogen receptor modulator.
The average daily dose of 17β-estradiol for replacement therapy formulated in a patch delivered by the transdermal route is between 50 and 100 μg.
Estrogen pharmacology: indications, oral formulations, and doses of commonly prescribed estrogen compounds
Indication . | Oral formulation or type . | Daily therapy doses . |
---|---|---|
Estrogen replacement | Micronized 17β-estradiola | 1-2 mg |
Estradiol valerate | 1-2 mg | |
Conjugated equine estrogen | 0.3-1.25 mg | |
Contraception | Ethinyl estradiol | 20-50 μg |
Other | SERM | |
Osteoporosis | Raloxifene | 60 mg |
Breast cancer prophylaxis | Tamoxifen | 20 mg |
Infertility | Clomiphene | 50 mg |
Indication . | Oral formulation or type . | Daily therapy doses . |
---|---|---|
Estrogen replacement | Micronized 17β-estradiola | 1-2 mg |
Estradiol valerate | 1-2 mg | |
Conjugated equine estrogen | 0.3-1.25 mg | |
Contraception | Ethinyl estradiol | 20-50 μg |
Other | SERM | |
Osteoporosis | Raloxifene | 60 mg |
Breast cancer prophylaxis | Tamoxifen | 20 mg |
Infertility | Clomiphene | 50 mg |
Abbreviation: SERM, selective estrogen receptor modulator.
The average daily dose of 17β-estradiol for replacement therapy formulated in a patch delivered by the transdermal route is between 50 and 100 μg.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.